Money A2Z Web Search

Search results

1. Results From The WOW.Com Content Network

2. Athersys' (ATHX) MultiStem Cell Therapy Succeeds in Study - AOL

   www.aol.com/news/athersys-athx-multistem-cell...

   Athersys (ATHX) gains on encouraging results from its exploratory study on the intravenous administration of MultiStem cell therapy to treat patients suffering from ARDS.

3. Were Hedge Funds Right About Souring On Athersys, Inc. (ATHX)?

   www.aol.com/news/were-hedge-funds-souring...

   For premium support please call: 800-290-4726 more ways to reach us

4. Hedge Funds Are Selling Athersys, Inc. (ATHX) - AOL

   www.aol.com/news/hedge-funds-selling-athersys...

   For premium support please call: 800-290-4726 more ways to reach us

5. List of largest biomedical companies by revenue - Wikipedia

   en.wikipedia.org/wiki/List_of_largest_biomedical...

   The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.

6. Financial News Network - Wikipedia

   en.wikipedia.org/wiki/Financial_News_Network

   The Financial News Network (FNN) was an American financial and business news television network launched on November 30, 1981. The network aimed to broadcast programming nationwide, five days a week, for seven hours a day on thirteen stations, in an effort to expand the availability of business news for public dissemination.

7. Patrick Soon-Shiong - Wikipedia

   en.wikipedia.org/wiki/Patrick_Soon-Shiong

   Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer.

8. Athersys (ATHX) Down as Ischemic Stroke Study Fails to ... - AOL

   www.aol.com/news/athersys-athx-down-ischemic...

   While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.

9. Jason Pontin - Wikipedia

   en.wikipedia.org/wiki/Jason_Pontin

   Jason Matthew Daniel Pontin (born 11 May 1967) is a British-born venture capitalist and journalist. He is a General Partner at the venture capital firm of DCVC in Palo Alto, and is a board member and seed investor in a number of life sciences companies.